PharmaJet Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 23

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 17

PharmaJet General Information

Description

Developer of needle-free fluid injection devices designed to deliver vaccines, therapeutics, and drugs without the use of needles. The company offers devices capable of delivering injections into intradermal, subcutaneous, and intramuscular tissues, enabling healthcare providers to administer medications while reducing needlestick injuries, cross-contamination risks, and sharps waste.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 400 Corporate Circle
  • Suite N
  • Golden, CO 80401
  • United States
+1 (888)
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 400 Corporate Circle
  • Suite N
  • Golden, CO 80401
  • United States
+1 (888)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmaJet Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
19. Secondary Transaction - Private Completed Generating Revenue
18. Grant 20-Sep-2022 Completed Generating Revenue
17. Later Stage VC 26-Apr-2021 Completed Generating Revenue
16. Later Stage VC (Series H) 10-Jun-2020 Completed Generating Revenue
15. Grant 17-Mar-2020 Completed Generating Revenue
14. Later Stage VC (Series G) 31-Jan-2020 Completed Generating Revenue
13. Later Stage VC (Series G) 22-Jan-2019 Completed Generating Revenue
12. Later Stage VC (Series F) 20-Apr-2018 Completed Generating Revenue
11. Later Stage VC (Series E) 21-Feb-2018 $6.01M $35.3M Completed Generating Revenue
10. Accelerator/Incubator 01-Jun-2017 $29.3M Completed Generating Revenue
To view PharmaJet’s complete valuation and funding history, request access »

PharmaJet Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series H
Series G1
Series F
Series E
Series D1
Series D
Series C2
Series C1
Series C 1,171,421 $0.000010 $0.28 $3.5 $3.5 1x $3.5 4.64%
Series B1 897,620 $0.000010 $0.52 $6.51 $6.51 1x $6.51 3.55%
To view PharmaJet’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

PharmaJet Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of needle-free fluid injection devices designed to deliver vaccines, therapeutics, and drugs without the use o
Medical Supplies
Golden, CO
23 As of 2026

Hamilton, Australia
 

Nes Ziona, Israel
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PharmaJet Competitors (4)

One of PharmaJet’s 4 competitors is Vaxxas, a Venture Capital-Backed company based in Hamilton, Australia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vaxxas Venture Capital-Backed Hamilton, Australia
NanoPass Technologies Venture Capital-Backed Nes Ziona, Israel
Portal Instruments Venture Capital-Backed Cambridge, MA
Crossject Formerly VC-backed Dijon, France
To view PharmaJet’s complete competitors history, request access »

PharmaJet Patents

PharmaJet Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023428116-A1 Needle-free injector dose setting apparatus and methods Pending 02-Feb-2023
EP-4658338-A1 Needle-free injector dose setting apparatus and methods Pending 02-Feb-2023
US-12642915-B2 Needle-free injector dose setting apparatus and methods Active 02-Feb-2023
US-20240261514-A1 Needle-free injector dose setting apparatus and methods Active 02-Feb-2023
US-20260273198-A1 Needle-free injector dose setting apparatus and methods Pending 02-Feb-2023 A61M5/3243
To view PharmaJet’s complete patent history, request access »

PharmaJet Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PharmaJet Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Cancer Institute Government
AngelMD Angel Group
Cliintel Capital Management Group Venture Capital Minority
Daicel Corporation Minority
Development Innovation Ventures Impact Investing
You’re viewing 5 of 17 investors. Get the full list »

PharmaJet FAQs

  • When was PharmaJet founded?

    PharmaJet was founded in 2005.

  • Where is PharmaJet headquartered?

    PharmaJet is headquartered in Golden, CO.

  • What is the size of PharmaJet?

    PharmaJet has 23 total employees.

  • What industry is PharmaJet in?

    PharmaJet’s primary industry is Medical Supplies.

  • Is PharmaJet a private or public company?

    PharmaJet is a Private company.

  • What is PharmaJet’s current revenue?

    The current revenue for PharmaJet is .

  • How much funding has PharmaJet raised over time?

    PharmaJet has raised $74.9M.

  • Who are PharmaJet’s investors?

    National Cancer Institute, AngelMD, Cliintel Capital Management Group, Daicel, and Development Innovation Ventures are 5 of 17 investors who have invested in PharmaJet.

  • Who are PharmaJet’s competitors?

    Vaxxas, NanoPass Technologies, Portal Instruments, and Crossject are competitors of PharmaJet.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process